Literature DB >> 12686883

Probiotics, infection and immunity.

George T Macfarlane1, John H Cummings.   

Abstract

PURPOSE OF REVIEW: Taking live bacteria by mouth to improve health (probiotics) is not intuitively rational yet it is a practice with a long history. As interest in the effects on health of the intestinal flora has developed, along with major advances in the technology for studying it, so has come a new interest in establishing the true benefits of probiotic therapy. This review summarizes the most recent contributions to this rapidly developing area. RECENT
FINDINGS: Probiotic bacteria, mainly bifidobacteria and lactobacilli for historical reasons, can prevent or ameliorate some diseases. Many empirical studies have been done, but work to develop the ideal characteristics of probiotics lags behind. Current literature covers survival of probiotics in the gut, mucosal adherence, antibacterial/pathogen mechanisms, effects on immune function and clinical studies.
SUMMARY: Probiotic bacteria are effective in preventing and reducing the severity of acute diarrhoea in children. They are also useful in antibiotic associated diarrhoea but not for elimination of Helicobacter pylori. In inflammatory bowel disease, especially ulcerative colitis, probiotics offer a safe alternative to current therapy. Probiotics have been used to prevent urogenital tract infection with benefit and, perhaps more intriguingly, to reduce atopy in children. Probiotics do not invariably work and study of mechanisms is urgently needed.

Entities:  

Mesh:

Year:  2002        PMID: 12686883     DOI: 10.1097/00001432-200210000-00008

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  24 in total

1.  Are probiotics detectable in human feces after oral uptake by healthy volunteers?

Authors:  Martina Prilassnig; Christoph Wenisch; Florian Daxboeck; Gebhard Feierl
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

2.  Lactobacillus reuteri in the treatment of Helicobacter pylori infection.

Authors:  Maria Pina Dore; Marianna Cuccu; Gianni Mario Pes; Alessandra Manca; David Yates Graham
Journal:  Intern Emerg Med       Date:  2013-11-01       Impact factor: 3.397

3.  Macrolide resistance and in vitro selection of resistance to antibiotics in Lactobacillus isolates.

Authors:  Lorenzo Drago; Roberto Mattina; Lucia Nicola; Valentina Rodighiero; Elena De Vecchi
Journal:  J Microbiol       Date:  2011-09-02       Impact factor: 3.422

4.  Practical identification of human originated Lactobacillus species by amplified ribosomal DNA restriction analysis (ARDRA) for probiotic use.

Authors:  Mehmet Öztürk; Merve Meterelliyöz
Journal:  Mol Biol Rep       Date:  2015-04-10       Impact factor: 2.316

5.  Potentially probiotic bacteria induce efficient maturation but differential cytokine production in human monocyte-derived dendritic cells.

Authors:  Sinikka Latvala; Taija-E Pietila; Ville Veckman; Riina-A Kekkonen; Soile Tynkkynen; Riitta Korpela; Ilkka Julkunen
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

Review 6.  The dual role of bacteriocins as anti- and probiotics.

Authors:  O Gillor; A Etzion; M A Riley
Journal:  Appl Microbiol Biotechnol       Date:  2008-10-14       Impact factor: 4.813

7.  Rapidly progressive kidney failure induced by fungal mycelia obstructing indwelling ureteral stents.

Authors:  Marie Dubert; Valeria Loi; Mohamed Tligui; Alexandre Hertig
Journal:  BMJ Case Rep       Date:  2012-12-14

8.  Probiotics and blueberry attenuate the severity of dextran sulfate sodium (DSS)-induced colitis.

Authors:  Nadia Osman; Diya Adawi; Siv Ahrné; Bengt Jeppsson; Göran Molin
Journal:  Dig Dis Sci       Date:  2008-02-15       Impact factor: 3.199

9.  Randomised clinical trial of synbiotic therapy in elective surgical patients.

Authors:  A D G Anderson; C E McNaught; P K Jain; J MacFie
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

10.  Salmonella enterica serovar Typhimurium adhesion and cytotoxicity during epithelial cell stress is reduced by Lactobacillus rhamnosus GG.

Authors:  Kristin M Burkholder; Arun K Bhunia
Journal:  Gut Pathog       Date:  2009-07-09       Impact factor: 4.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.